STOCK TITAN

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

iRhythm Technologies (NASDAQ:IRTC) will present at the 44th Annual J.P. Morgan Healthcare Conference.

Management is scheduled to present on Monday, January 12, 2026 at 8:15 a.m. PT / 11:15 a.m. ET. A live and archived webcast will be available in the Events and Presentations section of the company investor website at investors.irhythmtech.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Conference edition 44th Annual J.P. Morgan Healthcare Conference
Presentation date January 12, 2026 Scheduled management presentation
Presentation time PT 8:15 a.m. PT Conference session time
Presentation time ET 11:15 a.m. ET Conference session time

Market Reality Check

$178.57 Last Close
Volume Volume 292,922 vs 20-day average 421,596 (relative volume 0.69), indicating subdued trading ahead of the event. low
Technical Price 178.6 is trading above the 200-day MA of 151.7, reflecting a pre-existing uptrend before this conference news.

Peers on Argus

IRTC was up 0.46% while peers were mixed: BRKR gained 1.09%, GKOS, MASI, BIO, and GMED were modestly negative. This points to stock-specific dynamics rather than a broad Medical Devices move.

Historical Context

Date Event Sentiment Move Catalyst
Nov 21 Clinical data update Positive +4.8% Large APHRS 2025 analysis supported Zio monitoring performance across Asian populations.
Nov 11 Publication & data Positive +0.0% Heart Rhythm study and AHA data highlighted benefits of long-term Zio monitoring.
Nov 04 Investor conferences Neutral -0.3% Outlined multiple upcoming investor conference presentations and webcast access.
Oct 30 Quarterly earnings Positive -0.6% Q3 2025 revenue growth, margin expansion, narrowed losses, and higher full‑year guidance.
Oct 16 Earnings notice Neutral +0.4% Announced timing and webcast details for upcoming Q3 2025 results call.
Pattern Detected

Recent news has generally seen price moves aligned with the tone of announcements, with one notable divergence on strong Q3 2025 earnings where shares slipped modestly despite positive fundamentals.

Recent Company History

Over the last few months, iRhythm reported strong Q3 2025 growth with higher guidance, supported by multiple large-scale Zio® monitoring studies and conference data in November 2025. These clinical and real‑world results reinforced the performance and generalizability of its long‑term continuous ECG monitoring platform. The company also maintained active investor outreach through several conferences. Today’s announcement of a presentation at the 44th J.P. Morgan Healthcare Conference extends that investor engagement trajectory rather than marking a new clinical or financial inflection.

Market Pulse Summary

This announcement highlights iRhythm’s participation in the influential 44th J.P. Morgan Healthcare Conference on January 12, 2026. It continues a recent pattern of active investor engagement following strong Q3 2025 growth and multiple large-scale Zio® monitoring studies. Investors may focus on any incremental detail management shares there on strategy, growth drivers, or pipeline. Key watchpoints remain execution versus raised guidance, evolving clinical evidence, and ongoing insider and regulatory disclosures.

AI-generated analysis. Not financial advice.

SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference.

iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events and Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact
Stephanie Zhadkevich
investors@irhythmtech.com

Media Contact
Kassandra Perry
irhythm@highwirepr.com


FAQ

When will iRhythm (IRTC) present at the 44th Annual J.P. Morgan Healthcare Conference?

iRhythm management will present on Monday, January 12, 2026 at 8:15 a.m. PT / 11:15 a.m. ET.

Where can investors watch the iRhythm (IRTC) J.P. Morgan presentation webcast?

A live and archived webcast will be available on the company investor website under Events and Presentations at investors.irhythmtech.com.

What topics will iRhythm (IRTC) cover at the J.P. Morgan Healthcare Conference presentation?

The announcement states management will present company developments and outlook; specific presentation topics were not listed.

Is the iRhythm (IRTC) J.P. Morgan presentation available after the live event?

Yes, an archived webcast will be posted on the company’s investor website after the live presentation.

How do I find the exact webcast link for iRhythm (IRTC) presentations?

Go to investors.irhythmtech.com and open the Events and Presentations section to find the live and archived webcast links.

What time is iRhythm's (IRTC) presentation in Eastern Time on January 12, 2026?

The presentation is scheduled for 11:15 a.m. Eastern Time on January 12, 2026.
Irhythm Technologies Inc

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Latest SEC Filings

IRTC Stock Data

5.75B
31.77M
0.94%
112.45%
8.64%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
San Francisco